{"id":1114,"date":"2018-03-01T20:48:08","date_gmt":"2018-03-01T20:48:08","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1114"},"modified":"2026-02-24T15:56:57","modified_gmt":"2026-02-24T15:56:57","slug":"practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/","title":{"rendered":"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson)"},"content":{"rendered":"<p>This is an update of previous 2001 Canadian guidelines on how doctors and diagnostic lab specialists should use and interpret a technology called chromosomal microarray analysis (CMA) when this test is done on human DNA during an ongoing pregnancy. The authors developed these guidelines after reading and interpreting up-to-date international literature in the field, and discussing recommendations specific to the Canadian health care system. CMA should be offered after expert counselling of the family, in situations when birth defects are present and when an entire extra or missing chromosome is not likely to be the cause of these birth defects. (<a href=\"http:\/\/jmg.bmj.com\/content\/early\/2018\/03\/01\/jmedgenet-2017-105013\">http:\/\/jmg.bmj.com\/content\/early\/2018\/03\/01\/jmedgenet-2017-105013<\/a> )<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This is an update of previous 2001 Canadian guidelines on how doctors and diagnostic lab specialists should use and interpret a technology called chromosomal microarray analysis (CMA) when this test is done on human DNA during an ongoing pregnancy. The authors developed these guidelines after reading and interpreting up-to-date international literature in the field, and [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1114","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"This is an update of previous 2001 Canadian guidelines on how doctors and diagnostic lab specialists should use and interpret a technology called chromosomal microarray analysis (CMA) when this test is done on human DNA during an ongoing pregnancy. The authors developed these guidelines after reading and interpreting up-to-date international literature in the field, and [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-01T20:48:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T15:56:57+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson)\",\"datePublished\":\"2018-03-01T20:48:08+00:00\",\"dateModified\":\"2026-02-24T15:56:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/\"},\"wordCount\":135,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/\",\"name\":\"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2018-03-01T20:48:08+00:00\",\"dateModified\":\"2026-02-24T15:56:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/03\\\/01\\\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/","og_locale":"en_US","og_type":"article","og_title":"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson) - JMG Contact blog","og_description":"This is an update of previous 2001 Canadian guidelines on how doctors and diagnostic lab specialists should use and interpret a technology called chromosomal microarray analysis (CMA) when this test is done on human DNA during an ongoing pregnancy. The authors developed these guidelines after reading and interpreting up-to-date international literature in the field, and [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/","og_site_name":"JMG Contact blog","article_published_time":"2018-03-01T20:48:08+00:00","article_modified_time":"2026-02-24T15:56:57+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson)","datePublished":"2018-03-01T20:48:08+00:00","dateModified":"2026-02-24T15:56:57+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/"},"wordCount":135,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/","url":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/","name":"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2018-03-01T20:48:08+00:00","dateModified":"2026-02-24T15:56:57+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/03\/01\/practice-guideline-joint-ccmg-sogc-recommendations-for-the-use-of-chromosomal-microarray-analysis-for-prenatal-diagnosis-and-assessment-of-fetal-loss-in-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada (Contributed by Dr. W.T. Gibson)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1114"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1114\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}